China Money Network
Login
Join

Qiming Leads $29M Round In Chinese Antibody Drug Developer Sino Biological

  • July 6, 2017 — 11:35 CST

This Data Is Locked!

This area is available only to Subscribers.

China-focused venture capital firm Qiming Venture Partners has led a RMB200 million (US$29 million) series A round in Sino Biological Inc., a Beijing-based recombinant protein... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: